Get access

Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura

Authors

  • Arwa Z. Al-Riyami MD,

    1. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Search for more papers by this author
  • James Lee MD,

    1. Division of Pediatric Neurology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada
    Search for more papers by this author
  • Mary Connolly MD, BCh,

    1. Division of Pediatric Neurology, Department of Pediatrics, University of British Columbia and British Columbia's Children's Hospital, Vancouver, British Columbia, Canada
    Search for more papers by this author
  • Evan Shereck MD

    Corresponding author
    1. Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada
    • Division of Pediatric Hematology/Oncology, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, CDRC-P, Portland, OR, United States.
    Search for more papers by this author

  • Conflict of interest: Nothing to report.

Abstract

We present a pediatric patient treated with high dose intravenous immunoglobulin (IVIG) for acute immune thrombocytopenic purpura (ITP), who developed cerebral sinus thrombosis in the absence of any identifiable hypercoagulable state. This report describes the successful management of this rare complication in this challenging setting. This report shows IVIG induced cerebral sinus thrombosis in ITP. Pediatr Blood Cancer 2011;57:157–159. © 2010 Wiley-Liss, Inc.

Ancillary